Professor of Medicine, Vanderbilt University
Hematology
Dr. Jeffrey A. Sosman, MD
|
|
Give Review
Jeffrey A. Sosman, MD practices Hematology. He went to Albert Einstein College of Medicine of Yeshiva University. He received 3 awards: "America's Top Doctors", "Nashville Lifestyles Magazine" and "America's Top Doctors for Cancer". Doctor Jeffrey A. Sosman, MD is a published doctor. He has 34 papers published. The most current publication "CUSTOM-SEQ: A Prototype for Oncology Rapid Learning in a Comprehensive EHR Environment." He accepts Medicare.
Publications
- Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.
- Melanoma and a Headache.
- Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma.
- Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies.
- Trametinib in the treatment of melanoma.
- Nivolumab in melanoma: latest evidence and clinical potential.
- Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addiction.
- Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells.
- Melanoma BRAF Fusions-Response.
- Clinically relevant genes and regulatory pathways associated with NRASQ61 mutations in melanoma through an integrative genomics approach.
- Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase 1/2 clinical trial.
- The High-Dose Aldesleukin "Select" Trial: A Trial to Prospectively Validate Predictive Models of Response Treatment in Patients with Metastatic Renal Cell Carcinoma.
- Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors.
- Adjuvant Vaccine Immunotherapy of Resected, Clinically Node-Negative Melanoma: Long-term Outcome and Impact of HLA Class I Antigen Expression on Overall Survival.
- Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients With BRAFV600-Mutant Melanoma Experiencing Progression With Single-Agent BRAF Inhibitor.
- Southwest Oncology Group S0008: A Phase III Trial of High-Dose Interferon Alfa-2b Versus Cisplatin, Vinblastine, and Dacarbazine DTIC, Plus Interleukin-2 and Interfero...
- Oral health in oncology: impact of immunotherapy.
- Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.
- Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation...
- BRAFV600E-Mutant Melanoma Presenting With Cardiac Involvement.
- Beyond Histology: Translating Tumor Genotypes into Clinically Effective Targeted Therapies.
- Spindle Cell Squamous Carcinoma During BRAF Inhibitor Therapy for Advanced Melanoma: An Aggressive Secondary Neoplasm of Undetermined Biologic Potential.
- The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma.
- Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma.
- Impact of MET expression on outcome in BRAF(V600E/K) advanced melanoma.
- Complications of targeted drug therapies for solid malignancies: manifestations and mechanisms.
- Update on the Targeted Therapy of Melanoma.
- Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor.
- Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials.
- Phase I/II trial of tremelimumab in patients with metastatic melanoma.
- A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal cell carcinoma: a Cytokine Working Group (CWG) study.
- CUSTOM-SEQ: A Prototype for Oncology Rapid Learning in a Comprehensive EHR Environment.
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.
Schools
A Einstein Col Med Yeshiva Univ
University of Chicago
University Of Wisconsin Madison
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Assurant Health
- Blue Card PPO
- Network S
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Coventry Health Care of Tennessee PPO
- GEHA
- Choice Care PPO
- Medicaid
- Medicare MCR
- PHCS Network PPO
- POMCO Group
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- America's Top Doctors
- Nashville Lifestyles Magazine
- America's Top Doctors for Cancer
Education
-
University of Wisconsin -
University of Chicago -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1699862706 | |
| NPPES Provider LastName | SOSMAN | |
| NPPES Provider FirstName | JEFFREY | |
| NPPES Provider ZIPCode | 372320001 | |
| NPPES Provider State | TN | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 559.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 60.0 | |
| Percent Opioid Claims | 10.73 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699862706 |
| Last Name Of The Provider | SOSMAN |
| First Name Of The Provider | JEFFREY |
| View All |
Similar Doctors
|
Dr. Nishitha M. Reddy, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian G. Engelhardt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wichai Chinratanalab, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffery F. Patton, MD |
|
|
Dr. Emily Chan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert S. Cooper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael T. Lomis, MD |
|
|
Dr. Olalekan O. Oluwole, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jia Bi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jill Gilbert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Graham T. Watson, MD |
|
|
Shaoying Li, MB |
|
|
Hava Fife, APRN |